131 related articles for article (PubMed ID: 32229804)
1. Intensity-modulated radiation therapy in early stage squamous cell carcinoma of the larynx: treatment trends and outcomes.
Wegner RE; Abel S; Bergin JJ; Colonias A
Radiat Oncol J; 2020 Mar; 38(1):11-17. PubMed ID: 32229804
[TBL] [Abstract][Full Text] [Related]
2. Trends in intensity-modulated radiation therapy use for rectal cancer in the neoadjuvant setting: a National Cancer Database analysis.
Wegner RE; Abel S; White RJ; Horne ZD; Hasan S; Kirichenko AV
Radiat Oncol J; 2018 Dec; 36(4):276-284. PubMed ID: 30630266
[TBL] [Abstract][Full Text] [Related]
3. Predictors of IMRT and conformal radiotherapy use in head and neck squamous cell carcinoma: a SEER-Medicare analysis.
Sher DJ; Neville BA; Chen AB; Schrag D
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e197-206. PubMed ID: 21596483
[TBL] [Abstract][Full Text] [Related]
4. Outcomes after radiation therapy for T2N0/stage II glottic squamous cell carcinoma.
Al Feghali KA; Youssef BY; Mohamed ASR; Hilal L; Smith BD; Abu-Gheida I; Farha G; Gunn GB; Phan J; Lewin J; Thekdi A; Morrison WH; Garden AS; Fuller CD; Rosenthal DI
Head Neck; 2020 Oct; 42(10):2791-2800. PubMed ID: 32484591
[TBL] [Abstract][Full Text] [Related]
5. Outcomes between intensity-modulated radiation therapy versus 3D-conformal in early stage glottic cancer.
Amini A; Morgan R; Meyer E; Fakhoury K; Ladbury C; Bickett T; McDermott JD; Stokes W; Karam SD
Head Neck; 2021 Nov; 43(11):3393-3403. PubMed ID: 34382714
[TBL] [Abstract][Full Text] [Related]
6. Intensity-Modulated Radiation Therapy for Early-Stage Squamous Cell Carcinoma of the Glottic Larynx: A Systematic Review and Meta-Analysis.
Razavian NB; D'Agostino RB; Shenker RF; Hughes RT
Int J Radiat Oncol Biol Phys; 2023 Nov; 117(3):652-663. PubMed ID: 37150263
[TBL] [Abstract][Full Text] [Related]
7. Intensity-modulated radiotherapy improves survival and reduces treatment time in squamous cell carcinoma of the anus: A National Cancer Data Base study.
Elson JK; Kachnic LA; Kharofa JR
Cancer; 2018 Nov; 124(22):4383-4392. PubMed ID: 30329160
[TBL] [Abstract][Full Text] [Related]
8. Association of intensity-modulated radiation therapy on overall survival for patients with Hodgkin lymphoma.
Parikh RR; Grossbard ML; Harrison LB; Yahalom J
Radiother Oncol; 2016 Jan; 118(1):52-9. PubMed ID: 26522061
[TBL] [Abstract][Full Text] [Related]
9. A comparison of outcomes using intensity-modulated radiation therapy and 3-dimensional conformal radiation therapy in treatment of oropharyngeal cancer.
Lohia S; Rajapurkar M; Nguyen SA; Sharma AK; Gillespie MB; Day TA
JAMA Otolaryngol Head Neck Surg; 2014 Apr; 140(4):331-7. PubMed ID: 24557509
[TBL] [Abstract][Full Text] [Related]
10. Patterns of Care and Outcomes of Intensity-Modulated Radiotherapy and 3D Conformal Radiotherapy for Early Stage Glottic Cancer: A National Cancer Database Analysis.
Korpics MC; Turchan WT; Rooney MK; Koshy M; Spiotto MT
Cancers (Basel); 2019 Dec; 11(12):. PubMed ID: 31842271
[TBL] [Abstract][Full Text] [Related]
11. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
[TBL] [Abstract][Full Text] [Related]
12. Dosimetric comparison of helical tomotherapy, intensity-modulated radiation therapy, volumetric-modulated arc therapy, and 3-dimensional conformal therapy for the treatment of T1N0 glottic cancer.
Ekici K; Pepele EK; Yaprak B; Temelli O; Eraslan AF; Kucuk N; Altınok AY; Sut PA; Alpak OD; Colak C; Mayadagli A
Med Dosim; 2016 Winter; 41(4):329-333. PubMed ID: 27765542
[TBL] [Abstract][Full Text] [Related]
13. Three-dimensional conformal radiotherapy (3D-CRT) versus intensity modulated radiation therapy (IMRT) in squamous cell carcinoma of the head and neck: a randomized controlled trial.
Gupta T; Agarwal J; Jain S; Phurailatpam R; Kannan S; Ghosh-Laskar S; Murthy V; Budrukkar A; Dinshaw K; Prabhash K; Chaturvedi P; D'Cruz A
Radiother Oncol; 2012 Sep; 104(3):343-8. PubMed ID: 22853852
[TBL] [Abstract][Full Text] [Related]
14. Patterns of Care for Patients With Early-Stage Glottic Cancer Undergoing Definitive Radiation Therapy: A National Cancer Database Analysis.
Stokes WA; Abbott D; Phan A; Raben D; Lanning RM; Karam SD
Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1014-1021. PubMed ID: 28721883
[TBL] [Abstract][Full Text] [Related]
15. Dosimetric comparison of intensity-modulated radiation therapy for early-stage glottic cancers with and without the air cavity in the planning target volume.
Asher D; Amestoy W; Studenski MT; Samuels SE; Abramowitz MC; Freedman LM; Elsayyad N; Samuels MA
Med Dosim; 2019 Winter; 44(4):405-408. PubMed ID: 30928177
[TBL] [Abstract][Full Text] [Related]
16. Comparison of xerostomia incidence after three-dimensional conformal radiation therapy and contralateral superficial lobe parotid-sparing intensity-modulated radiotherapy for oropharyngeal and hypopharyngeal cancer.
Kawamoto T; Nihei K; Nakajima Y; Kito S; Sasai K; Karasawa K
Auris Nasus Larynx; 2018 Oct; 45(5):1073-1079. PubMed ID: 29397249
[TBL] [Abstract][Full Text] [Related]
17. Partial Laryngeal IMRT for T2N0 Glottic Cancer: Impact of Image Guidance and Radiation Therapy Intensification.
Rock K; Huang SH; Tiong A; Lu L; Xu W; Ringash J; Bratman SV; Tong L; Chan B; Cho J; Giuliani M; Hope A; Bayley A; Kim J; de Almeida JR; O'Sullivan B; Waldron J
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):941-949. PubMed ID: 29730062
[TBL] [Abstract][Full Text] [Related]
18. Patterns of care and outcomes of intensity modulated radiation therapy versus three-dimensional conformal radiation therapy for anal cancer.
Lee A; Albert A; Sheth N; Adedoyin P; Rowley J; Schreiber D
J Gastrointest Oncol; 2019 Aug; 10(4):623-631. PubMed ID: 31392042
[TBL] [Abstract][Full Text] [Related]
19. Carotid sparing intensity-modulated radiation therapy achieves comparable locoregional control to conventional radiotherapy in T1-2N0 laryngeal carcinoma.
Zumsteg ZS; Riaz N; Jaffery S; Hu M; Gelblum D; Zhou Y; Mychalczak B; Zelefsky MJ; Wolden S; Rao S; Lee NY
Oral Oncol; 2015 Jul; 51(7):716-23. PubMed ID: 25958831
[TBL] [Abstract][Full Text] [Related]
20. Trends in Radiation Dose and Technique For Anal Canal Squamous Cell Carcinoma.
Wegner RE; Abel S; Hasan S; White RJ; Raj M; Monga D; Finley G; McCormick J; Kirichenko AV
Am J Clin Oncol; 2019 Jun; 42(6):519-526. PubMed ID: 31136369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]